Lorna Jane, an Australian activewear company, was recently fined AU$5 million after claiming that its new line of active clothing can stop the spread of COVID-19. The firm said that its clothing could eliminate the virus, thus preventing its spread.
According to BBC News, Lorna Jane released advertisements that say it is using a groundbreaking technology called LJ Shield for its clothing line. It was claimed that this could stop the "transfer of all pathogens."
What the court says on Lorna Jane’s claims
Based on the report, a judge said in a ruling that the company’s claim about LJ Shield is "exploitative, predatory and potentially dangerous." The legal action against Lorna Jane was filed by the Australian Competition & Consumer Commission (ACCC) after the firm started selling its clothing in July amid the COVID-19 pandemic.
The verdict was said to have been released by the federal court on Friday, July 23. The judge said that based on investigations, Lorna Jane has been telling the consumers it has a “reasonable scientific or technological basis" for its claims about its clothing with the LJ Shield.
However, the judge said there was actually no scientific basis for such a claim. For this false and misleading representation to the public, the court slapped the company with a hefty fine.
"This was dreadful conduct as it involved making serious claims regarding public health when there was no basis for them," chairman of the ACCC, Rod Sims, said. "The whole marketing campaign was based upon consumers' desire for greater protection against the global pandemic."
Lorna Jane accepts the judge’s decision
The company was said to have accepted the verdict but explained, it was also misled by its supplier. Lorna Jane claimed its supplier sold them a product that did not deliver what it claimed to be, and they are referring to what they called the LJ Shield technology that is supposed to be anti-viral and anti-bacterial.
Meanwhile, it was learned that this is not the first time that Lorna Jane was fined. As per The Guardian, just in July 2020, the company was fined $40,000 for its failure to seek proper approval for ads from the Therapeutic Goods Administration. As for this new issue, the company issued an apology for its customers while continuing to blame its supplier for the issue.


Turkey Vehicle Sales Fall 11.4% in June as Auto Market Weakens
Asian Stocks Slide as Chip Shares Tumble Ahead of Key U.S. Jobs Report
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks
New Zealand Consumer Confidence Rises in June as Inflation Expectations Ease
Meta Stock Jumps as AI Cloud Expansion Challenges AWS, Microsoft, and Google
US Dollar Rises as Fed Rate Outlook Stays Hawkish, Euro Slips and Yen Near 40-Year Low
Trump Administration Declines USMCA Renewal, Opens Talks on New Trade Changes
Anthropic Tightens AI Access Controls After Reports of China-Based Workarounds
Asian Currencies Rise as Dollar Weakens; Yen Holds Steady Amid Japan Intervention Watch
Chinese Copper Foil Maker Londian Files U.S. IPO as EV Battery Demand Grows
Kawasaki Heavy Shares Slide on Report of ¥200 Billion Capital Raise Plan
Japan Signals Readiness to Act on Yen as Intervention Speculation Grows
BHP Workers Approve New Labour Agreement at WA Iron Ore Operations
Kioxia Bets on AI Memory Boom With Next-Gen NAND Production in Japan
Switch Seeks $2 Billion Funding at Nearly $50 Billion Valuation Ahead of Potential IPO
Wall Street Ends Mixed as Weak Jobs Data Lowers Fed Rate Hike Bets, Chip Stocks Tumble
Oil Prices Slip as Iran Talks and Strong Supply Outlook Ease Market Concerns 



